JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Cytokinetics
CYTK
$10.2B
| $23.7M | ﹤0.01% |
284,400
-101,701
| -26% | -$3.68M |
|
|
ARCH
1677
DELISTED
Arch Resources, Inc.
ARCH
| $23.7M | ﹤0.01% |
142,968
+10,383
| +8% | +$1.63M |
|
1678
Tenet Healthcare
THC
$21.5B
| $23.7M | ﹤0.01% |
313,649
-114,370
| -27% | -$7.25M |
|
1679
Avantis Emerging Markets Equity ETF
AVEM
$27B
| $23.7M | ﹤0.01% |
419,998
+324,293
| +339% | +$17.4M |
|
1680
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16.1B
| $23.6M | ﹤0.01% |
251,933
+74,063
| +42% | +$6.51M |
|
1681
Steven Madden
SHOO
$3.46B
| $23.6M | ﹤0.01% |
561,643
+78,379
| +16% | +$2.85M |
|
1682
QCR Holdings
QCRH
$1.75B
| $23.6M | ﹤0.01% |
403,575
+102,352
| +34% | +$5.3M |
|
1683
CALL
Pinduoduo
PDD
$120B
| $23.5M | ﹤0.01% |
+160,500
| New | +$19.5M |
|
1684
East-West Bancorp
EWBC
$18.6B
| $23.5M | ﹤0.01% |
326,142
+40,718
| +14% | +$2.45M |
|
1685
PUT
Nu Holdings
NU
$67.3B
| $23.4M | ﹤0.01% |
+2,814,800
| New | +$22.7M |
|
1686
Invesco NASDAQ 100 ETF
QQQM
$104B
| $23.4M | ﹤0.01% |
138,782
+37,744
| +37% | +$5.89M |
|
1687
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.43B
| $23.3M | ﹤0.01% |
550,552
+145,905
| +36% | +$5.81M |
|
1688
Semtech
SMTC
$12.4B
| $23.3M | ﹤0.01% |
1,064,713
+232,684
| +28% | +$4.32M |
|
1689
iShares Russell Top 200 ETF
IWL
$2.29B
| $23.3M | ﹤0.01% |
202,643
-16,964
| -8% | -$1.84M |
|
1690
UGI
UGI
$7.56B
| $23.3M | ﹤0.01% |
946,256
-30,228
| -3% | -$667K |
|
1691
GlobalFoundries
GFS
$28.9B
| $23.2M | ﹤0.01% |
382,130
-1,115,052
| -74% | -$61.8M |
|
1692
PUT
American Airlines Group
AAL
$9.97B
| $23.1M | ﹤0.01% |
1,684,200
+1,316,500
| +358% | +$16.5M |
|
1693
PUT
Dow Inc
DOW
$21.9B
| $23.1M | ﹤0.01% |
421,900
+51,700
| +14% | +$2.64M |
|
1694
Iovance Biotherapeutics
IOVA
$2.95B
| $23.1M | ﹤0.01% |
2,839,667
+93,311
| +3% | +$488K |
|
1695
Teekay Tankers
TNK
$2.9B
| $23.1M | ﹤0.01% |
461,283
+60,673
| +15% | +$2.91M |
|
1696
CALL
Procter & Gamble
PG
$335B
| $23M | ﹤0.01% |
156,800
+28,400
| +22% | +$4.21M |
|
1697
CALL
Nike
NKE
$61.2B
| $23M | ﹤0.01% |
211,400
+37,400
| +21% | +$4.02M |
|
1698
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
| $22.9M | ﹤0.01% |
345,044
+100,474
| +41% | +$6.31M |
|
1699
iShares MSCI Australia ETF
EWA
$1.45B
| $22.9M | ﹤0.01% |
938,973
+239,010
| +34% | +$5.3M |
|
1700
Avient
AVNT
$4.23B
| $22.9M | ﹤0.01% |
549,726
+35,656
| +7% | +$1.24M |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.